When to Initiate Antifungal Treatment in COVID-19 Patients with Secondary Fungal Co-infection

Author:

Pruthi Harnoor Singh

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Reference54 articles.

1. Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS ONE. 2021;16: e0251170. https://doi.org/10.1371/journal.pone.0251170. The study highlights the COVID-19 co-infections and superinfections. Provides timely and global prevalence of the existing data.

2. Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia 2020;185. https://doi.org/10.1007/s11046-020-00462-9.

3. Sen M, Honavar S, Sengupta S, Rao R, Kim U, Sharma M, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India — Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 69: 2021. https://doi.org/10.4103/ijo.IJO_1565_21. Provides Indian data on infection prevalence and management approaches.

4. Naveen KV, Saravanakumar K, Sathiyaseelan A, MubarakAli D, Wang M-H. Human fungal infection, immune response, and clinical challenge—a perspective during COVID-19 pandemic. Appl Biochem Biotechnol. 2022. https://doi.org/10.1007/s12010-022-03979-5. Detailed perspective on fungal coinfections in COVID-19, the immune response, and the clinical challenge posed by them.

5. Gangneux J-P, Bougnoux M-E, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J de Mycol Méd. 2020;30: 100971. https://doi.org/10.1016/j.mycmed.2020.100971.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Invasive Pulmonary Aspergillosis;Journal of Fungi;2023-01-17

2. The Role of COVID-19 in Antibiotic Resistance in Pediatric Population;Pediatric pharmacology;2023-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3